selected publications
-
academic article
- Cannabidiol repairs behavioral and brain disturbances in a model of fetal alcohol spectrum disorder. PHARMACOLOGICAL RESEARCH. 106655-106676. 2023
- Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model. FRONTIERS IN PHARMACOLOGY. 117164-117166. 2023
- Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice. PHARMACEUTICALS. 1-19. 2022
- Role of cannabidiol in therapeutic intervention for substance use disorders. FRONTIERS IN PHARMACOLOGY. 1-24. 2021
- Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality. FRONTIERS IN PSYCHIATRY. 1-14. 2020
- Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders. BIOMOLECULES. 1-34. 2020
- Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences. FRONTIERS IN PSYCHIATRY. 1-15. 2020
- Endocannabinoid System Components as Potential Biomarkers in Psychiatry. FRONTIERS IN PSYCHIATRY. 1-30. 2020
-
chapter
- Estrés temprano y sus consecuencias en la vida adulta. Neurobiología del Estrés Temprano. Respuesta del estrés durante la programación de la vida temprana.. 89-106. 2020
-
congress communication
- BEHAVIORAL, GENE EXPRESSION AND IMMUNOHISTOCHEMICAL ALTERATIONS INDUCED BY AN ANIMAL MODEL OF FASD ARE MODULATED BY CANNABIDIOL ADMINISTRATION 2023
- BEHAVIORAL, GENE, AND PROTEIN NEUROADAPTATIONS ASSOCIATED WITH CANNABIDIOL-MEDIATED MODULATION IN AN ANIMAL MODEL OF PERINATAL ALCOHOL EXPOSURE 2023
- Cannabidiol-induced modulation of behavioral, cellular and gen eepression changes in an animal model of FASD 2022
- Fast antidepressant-like effects of cannabidiol in the chronic mild stress model in mice 2022